Medicine and Dentistry
Systemic Lupus Erythematosus
81%
Nephropathy
57%
Infection
50%
Immunocompetent Cell
50%
Secondary Infection
50%
Cystatin C
50%
Metabolic Syndrome
50%
Bacterial Pneumonia
50%
Insulin Resistance
50%
Von Willebrand Factor Cleaving Proteinase
50%
Fibrinolysis
50%
C Reactive Protein
50%
Vitamin D
50%
Coagulopathy
50%
Pathophysiology
50%
Myositis
50%
COVID-19
50%
Cross-Link
50%
Glomerulus Basement Membrane
50%
Von Willebrand Factor
50%
Lupus Erythematosus
50%
Basement Membrane
50%
Virus Infection
33%
Diseases
25%
Serositis
22%
Glomerulopathy
22%
Surgical Site
16%
Lower Respiratory Tract Infection
16%
Immunosuppressive Treatment
16%
Rhinovirus
16%
Bacterial Infection
16%
Drive
16%
Immune Deficiency
16%
Urinary Tract Infection
16%
Chronic Disease
16%
Drug Therapy
16%
Mental Health
16%
Influenza Virus
16%
Innate Immunity
16%
Respiratory Syncytial Virus Infection
16%
National Health Service
16%
Malnutrition
16%
Autoantibodies
14%
Blood Clot Lysis
12%
Plasminogen Activator Inhibitor-1
12%
Cardiovascular Risk
12%
Blood Clotting
12%
Factor XIII
12%
Leukocyte Activation
12%
Disease Severity
12%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
81%
Myositis
50%
Metabolic Syndrome X
50%
Bacterial Pneumonia
50%
Von Willebrand Factor Cleaving Proteinase
50%
Von Willebrand Factor
50%
Infection
50%
Secondary Infection
50%
Blood Clotting Disorder
50%
Cystatin C
50%
Pathophysiology
50%
Insulin Resistance
50%
C Reactive Protein
50%
Vitamin D
50%
Virus Infection
33%
Inflammation
26%
Disease Severity
20%
Plasminogen Activator Inhibitor 1
20%
Blood Clotting Factor 13
20%
Malnutrition
16%
Lower Respiratory Tract Infection
16%
Bacterial Infection
16%
Immune Deficiency
16%
Urinary Tract Infection
16%
Rhinovirus
16%
Influenza Virus
16%
Chronic Disease
16%
Respiratory Syncytial Virus Infection
16%
Autoantibodies
14%
Disease
14%
Cardiovascular Risk
12%
Thrombus
10%
Prevalence
10%
Fibrinolytic Agent
10%
Disintegrin
10%
Polymer
10%
Procoagulant
10%
Interleukin 6
10%
Plasmin
10%
Metalloproteinase
10%
Thrombospondin
10%
Calcinosis
7%
Autoimmune Disease
7%
Biological Marker
7%
Kidney Disease
7%
Comorbidity
7%
Enzyme-Linked Immunosorbent Assay
7%
Glucocorticoid
6%
High Density Lipoprotein
6%
Hypertriglyceridemia
6%
Immunology and Microbiology
COVID-19
100%
Immunocompetent Cell
56%
Cross Linking
50%
Immunodeficiency
50%
Innate Immune System
50%
Respiratory Syncytial Virus Infection
50%
Acute Inflammation
50%
Lower Respiratory Tract
50%
Urinary Tract
50%
Influenza Virus
50%
Mental Health
50%
Rhinovirus
50%
Fibrinolysis
50%
Immune Response
31%
Monocyte
18%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Neutrophil
12%
Blood Clot Lysis
12%
Neutrophil Granulocyte
12%
Blood Plasma
12%
Leukocyte Activation
12%
Blood Clotting
12%
Coronavirinae
12%
Upregulation
6%
Cell Cycle
6%
Inflammation Response
6%
Platelet
6%
Respiratory Virus
6%
Components of the Immune System
6%
Thrombocyte Activation
6%
Defensin
6%
Blood Level
6%
T Cell
6%
Prevalence
6%
Virus Cell Interaction
6%
Interleukin 6
6%
Severe Acute Respiratory Syndrome
6%
Vascularization
6%
Plasmin
6%
Fibrin Deposition
6%
Myelopoiesis
6%